Cargando…
Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters
We investigated the association of survivin expression with prognosis and other apoptosis-related biological factors in 110 primary ovarian cancer patients admitted to the Division of Gynecologic Oncology, Catholic University of Rome. Immunohistochemistry was performed on formalin-fixed, paraffin-em...
Autores principales: | Ferrandina, G, Legge, F, Martinelli, E, Ranelletti, F O, Zannoni, G F, Lauriola, L, Gessi, M, Gallotta, V, Scambia, G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361852/ https://www.ncbi.nlm.nih.gov/pubmed/15655541 http://dx.doi.org/10.1038/sj.bjc.6602332 |
Ejemplares similares
-
Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications
por: Ferrandina, G, et al.
Publicado: (2002) -
Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2006) -
Prognostic role of topoisomerase-IIα in advanced ovarian cancer patients
por: Ferrandina, G, et al.
Publicado: (2008) -
CD133 antigen expression in ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2009) -
Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor.
por: Scambia, G., et al.
Publicado: (1991)